A Dow Jones report says Russia has given conditional approval of Bayer’s $57 billion acquisition of Monsanto. Under the approval terms, Bayer agreed to transfer molecular breeding assets in several crops for a period of five years. The company didn’t specify who the Russian recipients of the transfer would be. Bayer says it’s agreed to grant non-discriminatory access to digital-farming technologies after the products have been launched in Russia. Bayer still plans on closing out the acquisition process in the second quarter of this year.
